A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2008

Conditions
Dysfunctional Central Venous Access Catheters
Interventions
DRUG

tenecteplase

"2 mL of reconstituted lyophilized tenecteplase instilled into lumen of dysfunctional CVC.~Patients weighing ≥ 30 kg received 2-mL instillations of tenecteplase (i.e., 2 mg of tenecteplase). Patients weighing \< 30 kg received instillations of tenecteplase equal to 110% of the internal lumen volume of the dysfunctional CVC. This dose was rounded to the nearest 0.1 mL and should not have exceeded 2 mL (2 mg)."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY